Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
D000243:Adenosine Deaminase / Q000172:deficiency*; D000255:Adenosine Triphosphate / Q000097:blood; D001803:Blood Transfusion; D003838:Deoxyadenine Nucleotides / Q000097:blood; D003839:Deoxyadenosines / Q000378:metabolism; D003841:Deoxycytidine / Q000627:therapeutic use*; D017707:Erythrocyte Transfusion; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000628:therapy*; D007231:Infant, Newborn; D007958:Leukocyte Count; D008297:Male; D009700:Nucleoside Deaminases / Q000172:deficiency*; D013601:T-Lymphocytes / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use*; D014020:Tissue Extracts / Q000627:therapeutic use*
D003838:Deoxyadenine Nucleotides; D003839:Deoxyadenosines; D013949:Thymus Extracts; D014020:Tissue Extracts; C031407:thymostimulin; D003841:Deoxycytidine; D000255:Adenosine Triphosphate; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase